Novartis withdraws application for EU approval of new arthritis &lt;b&gt;...&lt;/b&gt; The Swiss pharmaceutical group Novartis withdrew on Tuesday an application for EU approval of a new arthritis drug called Prexige to await a review of such treatments next year.